Skip to main content

Main menu

Home
Content
Subscriptions
Authors
Info
About
More
- Alerts
- Feedback
- Help
- SNMMI Journals

SNMMI
- JNM
- JNMT
- SNMMI Journals
- SNMMI

User menu

Subscribe
My alerts
Log in
My Cart

Search

Search for this keyword

Advanced search

SNMMI
- JNM
- JNMT
- SNMMI Journals
- SNMMI

Subscribe
My alerts
Log in
My Cart

Search for this keyword

Advanced Search

Home
Content
Subscriptions
Authors
Info
About
More
- Alerts
- Feedback
- Help
- SNMMI Journals

Follow SNMMI on Twitter
Visit SNMMI on Facebook
Follow SNMMI on Rss

Table of Contents

May 2009; Volume 50,Issue supplement 2

The Abstract Book Supplement to the Journal of Nuclear Medicine

Author index is not available for this issue.

In this issue

Journal of Nuclear Medicine

Vol. 50, Issue supplement 2

May 2009

Table of Contents
Index by author

Search for this keyword

Sign up for alerts

Most Cited
Most Read

First-in-Humans Imaging with ⁸⁹Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence Region
Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention
Diagnostic Evaluation of Pulmonary Embolism During the COVID-19 Pandemic
Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a ⁶⁸Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04

© 2021 Journal of Nuclear Medicine